Northern Trust
OYST

Northern Trust’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Northern Trust’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-39,501
Closed -$441K – 4706
2022
Q4 		$441K Buy
39,501
+4,444
+13% +$43.1K ﹤0.01% 3551
2022
Q3 		$197K Buy
35,057
+3,664
+12% +$22.9K ﹤0.01% 3880
2022
Q2 		$136K Sell
31,393
-73,280
-70% -$417K ﹤0.01% 4059
2022
Q1 		$1.22M Sell
104,673
-5,047
-5% -$60.1K ﹤0.01% 3338
2021
Q4 		$2M Sell
109,720
-1,419
-1% -$18K ﹤0.01% 3225
2021
Q3 		$1.32M Sell
111,139
-7,366
-6% -$107K ﹤0.01% 3454
2021
Q2 		$2.04M Buy
118,505
+27,113
+30% +$515K ﹤0.01% 3348
2021
Q1 		$1.67M Sell
91,392
-10,683
-10% -$224K ﹤0.01% 3343
2020
Q4 		$1.92M Buy
102,075
+2,583
+3% +$55.7K ﹤0.01% 3217
2020
Q3 		$2.1M Buy
99,492
+6,531
+7% +$153K ﹤0.01% 3040
2020
Q2 		$2.68M Buy
92,961
+23,872
+35% +$719K ﹤0.01% 2871
2020
Q1 		$2.42M Buy
69,089
+3,535
+5% +$114K ﹤0.01% 2748
2019
Q4 		$1.6M Buy
+65,554
New +$1.15M ﹤0.01% 3234

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northern Trust's OYST Position: Q1 2023 in Review

Northern Trust sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 39,501 shares — an estimated $441K sold.

Northern Trust first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $2.68M in Q2 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Northern Trust reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 39,501 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $441K.
  • Northern Trust first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Northern Trust's Oyster Point Pharma, Inc. Common Stock position peaked at $2.68M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.